0Suppliers
0Customers
2Debt Items
20Related Chains

Enliven Therapeutics, Inc. Suppliers

No suppliers on recordEnliven Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Enliven Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Enliven Therapeutics, Inc..

Enliven Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ELVN-DEBT-9276 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.
ELVN-DEBT Debt stack $302,000 90% Market cache reports total debt of $302,000.

Enliven Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Enliven Therapeutics, Inc..

Enliven Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
ELVN-OWNER-ORBIMED-ADVISORS-LLC ORBIMED ADVISORS LLC 90% 13F overlay lists ORBIMED ADVISORS LLC as top holder; 175 tracked holders.

Enliven Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ATOS Atossa Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2